We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$53.7B
AUM Growth
-$2.95B
Cap. Flow
+$168M
Cap. Flow %
0.31%
Top 10 Hldgs %
35.03%
Holding
1,742
New
57
Increased
475
Reduced
481
Closed
34

Sector Composition

Rank Sector Weight
1 Technology 31.44%
2 Financials 12.06%
3 Healthcare 11.81%
4 Communication Services 9.87%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BN icon
626
Brookfield
BN
$102B
$3.1M 0.01%
76,815
-12,700
-14% -$563K
ASND icon
627
Ascendis Pharma A/S
ASND
$16.5B
$3.1M 0.01%
13,562
-55,998
-81% -$12.6M
BNS icon
628
Scotiabank
BNS
$107B
$3.08M 0.01%
44,606
-4,800
-10% -$352K
IJH icon
629
iShares Core S&P Mid-Cap ETF
IJH
$123B
$3.06M 0.01%
45,369
MLYS icon
630
Mineralys Therapeutics
MLYS
$2.38B
$3.04M 0.01%
112,190
ATI icon
631
ATI
ATI
$26.7B
$3.03M 0.01%
20,815
+5,250
+34% +$731K
CPAY icon
632
Corpay
CPAY
$23.5B
$3.03M 0.01%
10,404
+3,100
+42% +$993K
CTSH icon
633
Cognizant
CTSH
$20.4B
$3.02M 0.01%
49,305
-1,099
-2% -$78.6K
SU icon
634
Suncor Energy
SU
$76.4B
$2.96M 0.01%
44,892
-9,900
-18% -$547K
TRU icon
635
TransUnion
TRU
$14.5B
$2.93M 0.01%
42,336
-50,589
-54% -$3.87M
TLN
636
Talen Energy Corp
TLN
$18B
$2.93M 0.01%
9,167
-6,726
-42% -$2.37M
ARES icon
637
Ares Management
ARES
$27B
$2.91M 0.01%
26,695
-196
-0.7% -$26K
ROKU icon
638
Roku
ROKU
$21.2B
$2.91M 0.01%
30,742
-8,762
-22% -$853K
BIOA
639
BioAge Labs
BIOA
$975M
$2.91M 0.01%
+166,224
New +$3.2M
CORT icon
640
Corcept Therapeutics
CORT
$9.76B
$2.89M 0.01%
71,781
+15,231
+27% +$570K
BR icon
641
Broadridge
BR
$16.7B
$2.88M 0.01%
17,754
-1,895
-10% -$360K
BBOT
642
BridgeBio Oncology
BBOT
$713M
$2.87M 0.01%
+320,874
New +$3.45M
ERIE icon
643
Erie Indemnity
ERIE
$11B
$2.87M 0.01%
11,411
-360
-3% -$96.6K
PPG icon
644
PPG Industries
PPG
$26.2B
$2.86M 0.01%
26,744
-2,988
-10% -$339K
AVY icon
645
Avery Dennison
AVY
$12.1B
$2.84M 0.01%
16,445
+7,970
+94% +$1.46M
TYRA icon
646
Tyra Biosciences
TYRA
$1.82B
$2.84M 0.01%
+74,064
New +$2.4M
NVR icon
647
NVR
NVR
$17.1B
$2.81M 0.01%
427
+96
+29% +$700K
CTMX icon
648
CytomX Therapeutics
CTMX
$725M
$2.78M 0.01%
+592,473
New +$3.01M
DUOL icon
649
Duolingo
DUOL
$5.57B
$2.77M 0.01%
28,110
-2,242
-7% -$276K
CRNX icon
650
Crinetics Pharmaceuticals
CRNX
$8.86B
$2.74M 0.01%
75,424
-200,192
-73% -$8.94M

Similar funds

Ensign Peak Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Ensign Peak Advisors held 1,742 positions worth $53.7B, down 5.2% from $56.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ensign Peak Advisors's Q1 2026 filing shows 57 new, 475 increased, 481 reduced and 34 closed positions. Its largest new stake was Novo Nordisk: 400,384 shares worth $14.7M. The largest sale was FTAI Aviation, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q1 2026 buy was Novo Nordisk: 400,384 shares worth $14.7M.
  • Ensign Peak Advisors added most to Boston Scientific in Q1 2026, an estimated $234M increase.
  • Ensign Peak Advisors's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $421M.
  • Ensign Peak Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $17M.
  • Ensign Peak Advisors's ten largest holdings make up 35% of its $53.7B portfolio in Q1 2026.
  • Ensign Peak Advisors opened 57 new positions and closed 34 in Q1 2026.
  • Ensign Peak Advisors's portfolio value fell 5.2% quarter-over-quarter to $53.7B.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.